NG

Healthcare · Pharmaceuticals

NGL Fine Chem Ltd (NGLFINE)

₹2,747.60

Mkt cap
₹1,880 Cr
P/E ratio
29.40
P/B
4.68
Div yield
0.06%
ROE
17.40%
ROCE
18.60%
EPS (TTM)
₹93.46
Book value
₹587
52W range
1,271–3,602
Sector
Healthcare

Price history

Previous close

Incorporated in 1981, NGL Fine-Chem Ltd is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health. [1]

NSE NGLFINEBSE 524774
Health check
Constructive
ValuationFair
ProfitabilityStrong
GrowthHigh
TechnicalsNeutral
52-week range
−23.72% from high
₹2,748
₹1,271+116.18% from low₹3,602
Current
₹2,747.60
Prev close
₹2,777.00
Day
−1.06%
Price performance
1D
−0.88%
1W
−9.49%
1M
+4.01%
3M
−9.25%
6M
+10.02%
1Y
+98.09%
YTD
+95.13%

Financials

Revenue, profit & margin
P/E ratio
29.4×
NGLFINE is 14% below the sector median of 34.0×
NGLFINE29.4×
Sector median34.0×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales808810091938995104120128149139159
YoY Sales growth+18%+22%+33%+28%+17%+1%-5%+15%+29%+43%+57%+34%+32%
Expenses6674848182848993103105128116131
Operating Profit14141691256111722212328
OPM %17%16%16%10%12%6%7%11%14%18%14%17%18%
Other Income34465-0-1625271
Interest0000011111111
Depreciation3333333455557
Profit before tax141416121311121321182422
Tax %25%30%23%22%26%-1%49%22%26%24%24%25%25%
Net Profit1010129101191016131816
EPS in Rs16.9616.2419.9414.9215.882.070.8714.9615.5925.4021.8429.7826.30
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +1.19% · closed higher next day 2 of last 3
 Q4FY26†Q1FY27Q2FY27
Broadcast12 Oct '26◦12 Aug '26◦6 Nov '26◦
Earnings day−0.82%+0.78%+3.62%
+1 day−1.17%+1.32%+3.60%
+5 days−9.58%−11.02%+0.42%
+15 days−8.55%−13.73%—
+30 days—−14.75%—
FilingXBRLXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
72.49%Promoter
Promoters72.49%
FIIs0.04%0.01
DIIs0.00%0.02
Public27.46%0.03
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
NGL Fine Chem₹3,041.3029.451,8800.06%16+68.74%159+31.97%18.58%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings